Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
-Medical News
 Blood Safety News
 NHF and Community News
 Industry News
 Travel Advisory

 

 

 
Source MDx Receives NIH Grant for New Diagnostic Test
 

Source MDx, a Colorado-based company that holds several health and disease-related patents for molecular diagnostic testing, was recently awarded a Small Business Innovation Research (SBIR) grant by the National Institutes of Health. The $100,000 award will fund the development of a molecular diagnostic test that would enable clinicians to gauge the health status of patients with hepatitis C (HCV). The technique involves measuring genetic material from the blood of HCV-infected patients in order to determine their response to treatment. An added benefit to this technique is that the procedure is less invasive than some other methods of measuring the health of HCV patients such as liver biopsy.

“Changes in gene expression in the blood from HCV patients could yield important foundational information for the development of a patient care diagnostic in the area of infectious diseases,” said Lisa Siconolfi, PhD, director of clinical studies at Source MDx. Source MDx currently holds more than 20 patents that similarly utilize “biomarker” analysis expertise used in preclinical and clinical drug development.

Source: Aging & Elder Health Week, February 5, 2006

 

This section of our Web site is sponsored by: